Development and Application of a Nanobody-Based Competitive ELISA for Detecting Antibodies against Hepatitis E Virus from Humans and Domestic Animals

ABSTRACT Hepatitis E virus (HEV) is a zoonotic pathogen that is widespread worldwide. At present, most enzyme-linked immunosorbent assay (ELISA) kits only detect antibodies against human HEV. In this study, a nanobody-horseradish peroxidase (HRP) fusion protein-based competitive ELISA (cELISA) with...

Full description

Bibliographic Details
Main Authors: Yiyang Chen, Meimei Zhang, Tianxiang Chen, Jiaxi Wang, Qin Zhao, En-Min Zhou, Baoyuan Liu
Format: Article
Language:English
Published: American Society for Microbiology 2023-08-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.03607-22
_version_ 1797741788294807552
author Yiyang Chen
Meimei Zhang
Tianxiang Chen
Jiaxi Wang
Qin Zhao
En-Min Zhou
Baoyuan Liu
author_facet Yiyang Chen
Meimei Zhang
Tianxiang Chen
Jiaxi Wang
Qin Zhao
En-Min Zhou
Baoyuan Liu
author_sort Yiyang Chen
collection DOAJ
description ABSTRACT Hepatitis E virus (HEV) is a zoonotic pathogen that is widespread worldwide. At present, most enzyme-linked immunosorbent assay (ELISA) kits only detect antibodies against human HEV. In this study, a nanobody-horseradish peroxidase (HRP) fusion protein-based competitive ELISA (cELISA) with more convenience and spectral characteristics for HEV antibody detection was developed and used to detect HEV IgG in various species. First, 6 anti-swine HEV capsid protein nanobodies were screened using phage display technology from an immunized Bactrian camel. Then, HEV-Nb67-HRP fusions were expressed and used as a probe for developing a cELISA. The cutoff value of the cELISA was 17.8%, and there was no cross-reaction with other anti-swine virus antibodies, suggesting that the cELISA had good specificity. The intra-assay and interassay coefficients of variation (CVs) were 1.33 to 5.06% and 1.52 to 6.84%, respectively. The cELISA and Western blot showed a higher coincidence rate (97.14%, kappa value = 0.927) than cELISA and indirect ELISA (95.00%, kappa value = 0.876) in clinical swine serum samples. Finally, the seroprevalence of HEV IgG in humans, pigs, rabbits, cows, and goats was 30.67%, 19.26%, 8.75%, 27.59%, and 18.08%, respectively, suggesting that cELISA may have a broader scale for mammalian HEV antibody detection. These results suggest that the newly developed cELISA was rapid, low-cost, reliable, and useful for the serological evaluation of current HEV. IMPORTANCE HEV is thought to be a zoonotic infection and is widespread worldwide; it is beneficial to establish a more convenient and spectral method for HEV antibody detection. In this study, a convenient, time-saving, reproducible, highly sensitive, specific, and novel nanobody-based cELISA was developed and can be used to detect IgG antibodies against mammalian HEV. It provides a new technique for serological evaluation and ELISA-based diagnosis of HEV infection.
first_indexed 2024-03-12T14:31:44Z
format Article
id doaj.art-c740c98872374d47b622560d8ae41f37
institution Directory Open Access Journal
issn 2165-0497
language English
last_indexed 2024-03-12T14:31:44Z
publishDate 2023-08-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj.art-c740c98872374d47b622560d8ae41f372023-08-17T13:04:14ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972023-08-0111410.1128/spectrum.03607-22Development and Application of a Nanobody-Based Competitive ELISA for Detecting Antibodies against Hepatitis E Virus from Humans and Domestic AnimalsYiyang Chen0Meimei Zhang1Tianxiang Chen2Jiaxi Wang3Qin Zhao4En-Min Zhou5Baoyuan Liu6Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, ChinaDepartment of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, ChinaDepartment of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, ChinaDepartment of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, ChinaDepartment of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, ChinaDepartment of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, ChinaDepartment of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, ChinaABSTRACT Hepatitis E virus (HEV) is a zoonotic pathogen that is widespread worldwide. At present, most enzyme-linked immunosorbent assay (ELISA) kits only detect antibodies against human HEV. In this study, a nanobody-horseradish peroxidase (HRP) fusion protein-based competitive ELISA (cELISA) with more convenience and spectral characteristics for HEV antibody detection was developed and used to detect HEV IgG in various species. First, 6 anti-swine HEV capsid protein nanobodies were screened using phage display technology from an immunized Bactrian camel. Then, HEV-Nb67-HRP fusions were expressed and used as a probe for developing a cELISA. The cutoff value of the cELISA was 17.8%, and there was no cross-reaction with other anti-swine virus antibodies, suggesting that the cELISA had good specificity. The intra-assay and interassay coefficients of variation (CVs) were 1.33 to 5.06% and 1.52 to 6.84%, respectively. The cELISA and Western blot showed a higher coincidence rate (97.14%, kappa value = 0.927) than cELISA and indirect ELISA (95.00%, kappa value = 0.876) in clinical swine serum samples. Finally, the seroprevalence of HEV IgG in humans, pigs, rabbits, cows, and goats was 30.67%, 19.26%, 8.75%, 27.59%, and 18.08%, respectively, suggesting that cELISA may have a broader scale for mammalian HEV antibody detection. These results suggest that the newly developed cELISA was rapid, low-cost, reliable, and useful for the serological evaluation of current HEV. IMPORTANCE HEV is thought to be a zoonotic infection and is widespread worldwide; it is beneficial to establish a more convenient and spectral method for HEV antibody detection. In this study, a convenient, time-saving, reproducible, highly sensitive, specific, and novel nanobody-based cELISA was developed and can be used to detect IgG antibodies against mammalian HEV. It provides a new technique for serological evaluation and ELISA-based diagnosis of HEV infection.https://journals.asm.org/doi/10.1128/spectrum.03607-22hepatitis E virus (HEV)cELISAantibodieshumansdomestic animals
spellingShingle Yiyang Chen
Meimei Zhang
Tianxiang Chen
Jiaxi Wang
Qin Zhao
En-Min Zhou
Baoyuan Liu
Development and Application of a Nanobody-Based Competitive ELISA for Detecting Antibodies against Hepatitis E Virus from Humans and Domestic Animals
Microbiology Spectrum
hepatitis E virus (HEV)
cELISA
antibodies
humans
domestic animals
title Development and Application of a Nanobody-Based Competitive ELISA for Detecting Antibodies against Hepatitis E Virus from Humans and Domestic Animals
title_full Development and Application of a Nanobody-Based Competitive ELISA for Detecting Antibodies against Hepatitis E Virus from Humans and Domestic Animals
title_fullStr Development and Application of a Nanobody-Based Competitive ELISA for Detecting Antibodies against Hepatitis E Virus from Humans and Domestic Animals
title_full_unstemmed Development and Application of a Nanobody-Based Competitive ELISA for Detecting Antibodies against Hepatitis E Virus from Humans and Domestic Animals
title_short Development and Application of a Nanobody-Based Competitive ELISA for Detecting Antibodies against Hepatitis E Virus from Humans and Domestic Animals
title_sort development and application of a nanobody based competitive elisa for detecting antibodies against hepatitis e virus from humans and domestic animals
topic hepatitis E virus (HEV)
cELISA
antibodies
humans
domestic animals
url https://journals.asm.org/doi/10.1128/spectrum.03607-22
work_keys_str_mv AT yiyangchen developmentandapplicationofananobodybasedcompetitiveelisafordetectingantibodiesagainsthepatitisevirusfromhumansanddomesticanimals
AT meimeizhang developmentandapplicationofananobodybasedcompetitiveelisafordetectingantibodiesagainsthepatitisevirusfromhumansanddomesticanimals
AT tianxiangchen developmentandapplicationofananobodybasedcompetitiveelisafordetectingantibodiesagainsthepatitisevirusfromhumansanddomesticanimals
AT jiaxiwang developmentandapplicationofananobodybasedcompetitiveelisafordetectingantibodiesagainsthepatitisevirusfromhumansanddomesticanimals
AT qinzhao developmentandapplicationofananobodybasedcompetitiveelisafordetectingantibodiesagainsthepatitisevirusfromhumansanddomesticanimals
AT enminzhou developmentandapplicationofananobodybasedcompetitiveelisafordetectingantibodiesagainsthepatitisevirusfromhumansanddomesticanimals
AT baoyuanliu developmentandapplicationofananobodybasedcompetitiveelisafordetectingantibodiesagainsthepatitisevirusfromhumansanddomesticanimals